9538
P. Mayo, W. Tam / Tetrahedron 58 (2002) 9527–9540
(
90 mL, 0.80 mmol), piperidine (0.180 mL, 1.81 mmol),
THF (1 mL) was added to a flame-dried vial containing
Pd(OAc)2 (12.2 mg, 0.0543 mmol) and PPh3 (28.3 mg,
0.108 mmol) via cannula and rinsed with THF (2£0.5 mL).
Iodobenzene (0.090 mL, 0.80 mmol), piperidine (0.180 mL,
1.81 mmol), and formic acid (0.050 mL, 1.3 mmol) were
added. The reaction mixture was stirred for 16 h at 608C.
After quenching with water (4 mL), the reaction mixture
and formic acid (50 mL, 1.3 mmol) were added. The
reaction mixture was stirred for 16 h at 608C. After
quenching with water (4 mL), the reaction mixture was
extracted with Et O (4£4 mL), and the combined organic
2
layers were dried (MgSO ). The solvent was removed by
4
rotary evaporation and the crude product was purified by
column chromatography (EtOAc/hexanes¼1:19) to give an
inseparable mixture of 46c and 47c (64.0 mg, 0.212 mmol,
8
1
was extracted with EtOAc (4£4 mL) and dried (MgSO ).
4
The solvent was removed by rotary evaporation and the
crude product was purified by column chromatography
(EtOAc/hexanes¼1:19) to give an inseparable mixture of
2%, 46c/47c¼74:26 measured by integration on 400 MHz
H NMR spectrum) as a colourless, transparent liquid. Rf
0
.44 (EtOAc/hexanes¼1:9); IR (neat) 3088 (w), 3063 (w),
026 (w), 2956 (s), 2930 (s), 2894 (s), 2856 (s), 1653 (w),
604 (w), 1494 (w), 1471 (m), 1361 (m), 1256 (s), 1180 (w),
46e and 47e (44.1 mg, 0.191 mmol, 70%, 46e/47e¼75:25
1
3
1
1
4
3
5
2
1
3
(
(
4
1
3
measured by integration on 400 MHz
spectrum) as a colourless, transparent liquid. R 0.27
H
NMR
f
152 (m), 1089 (s), 1018 (m) cm21; H NMR (CDCl ,
1
(EtOAc/hexanes¼1:19); IR (neat) 3060 (w), 3025 (w),
2954 (s), 2878 (m), 1736 (s), 1601 (w), 1494 (m), 1448 (m),
1435 (m), 1351 (m), 1305 (m), 1201 (s), 1168 (s), 1117 (w),
3
00 MHz) d 7.15–7.31 (m, 5H), 3.85 (d, 0.26H, J¼6.7 Hz),
.82 (dd, 0.74H, J¼8.5, 1.0 Hz), 2.62 (dd, 0.74H, J¼8.5,
.3 Hz), 2.52 (dd, 0.26H, J¼8.6, 6.2 Hz), 2.37 (s, 0.26H),
.36 (s, 0.74H), 2.26 (s, 0.26H), 2.20 (d, 0.74H, J¼3.7 Hz),
.78 (ddd, 0.74H, J¼12.8, 6.6, 1.9 Hz), 1.60–1.69 (m,
.26H), 1.43–1.46 (m, 2H), 0.90–0.91 (m, 9H), 0.07–0.08
1042 (m) cm2 ; H NMR (CDCl , 400 MHz) d 7.15–7.31
1 1
3
(m, 5H), 3.74 (s, 0.75H), 3.73 (s, 2.25H), 2.91–2.82 (m,
2H), 2.73 (d, 0.25H, J¼3.4 Hz), 2.68 (br s, 0.75H), 2.42–
1
3
2.45 (m, 1H), 1.59–1.89 (m, 5H), 1.35–1.41 (m, 1H); C
NMR (APT, CDCl , 100 MHz) major isomer (46e): d 175.4,
1
3
m, 6H); C NMR (APT, CDCl , 100 MHz) major isomer
3
3
46c): d 147.0, 128.2, 127.1, 125.48, 75.0, 46.3, 45.0, 43.9,
146.8, 128.2, 126.9, 125.5, 51.56, 46.43, 45.2, 43.3, 40.9,
37.9, 34.3, 33.0; minor isomer (47e): d 175.2, 146.2, 128.2,
127.1, 125.6, 51.64, 46.5, 46.39, 41.7, 38.0, 37.5, 37.4, 31.1.
Anal. calcd for C H O : C, 78.23; H, 7.88. Found C,
1.9, 33.4, 32.0, 25.94, 18.13, 24.6; minor isomer (47c): d
46.7, 128.3, 127.1, 125.52, 75.5, 51.0, 42.5, 42.3, 38.5,
5.7, 32.8, 25.90, 18.10, 24.7. Anal. calcd for C H OSi:
1
9
30
15 18 2
C, 75.43; H, 10.00. Found C, 75.63; H, 10.16.
77.93; H, 7.99.
4
(
.4.14. 2-exo-Acetoxy-5-exo-phenylbicyclo[2.2.1]heptane
46d) and 2-exo-acetoxy-6-exo-phenylbicyclo[2.2.1]hep-
tane (47d) (Table 3, entry 9). Pd(OAc)2 (6.5 mg,
.029 mmol), tetrabutylammonium chloride (81.4 mg,
.293 mmol), potassium formate (165.6 mg, 1.97 mmol),
4.4.16. 2-endo-Hydroxy-5-exo-phenylbicyclo[2.2.1]hep-
tane (46f) and 2-endo-hydroxy-6-exo-phenylbicyclo-
[2.2.1]heptane (47f) (Table 3, entry 11). A solution of
norbornene 4f (29.8 mg, 0.270 mmol) in THF (1 mL) was
0
0
added to a flame-dried vial containing Pd(OAc) (12.1 mg,
2
and iodobenzene (40 mL, 0.36 mmol) were added to a
solution of norbornene 4d (41.2 mg, 0.271 mmol) in DMF
0.0539 mmol) and PPh (28.1 mg, 0.107 mmol) via cannula
3
and rinsed with THF (2£0.5 mL). Iodobenzene (0.090 mL,
0.80 mmol), piperidine (0.180 mL, 1.81 mmol), and formic
acid (0.050 mL, 1.3 mmol) were added. The reaction
mixture was stirred for 21 h at 608C. After quenching with
(
2 mL). The reaction mixture was stirred for 96 h at room
temperature. After quenching with water (4 mL), the
reaction mixture was extracted with 1:9 CH Cl /hexanes
2
2
(
4£4 mL) and dried (MgSO ). The solvent was removed by
water (4 mL), the reaction mixture was extracted with Et O
2
4
rotary evaporation and the crude product was purified by
column chromatography (EtOAc/hexanes¼1:19) to give an
inseparable mixture of 46d and 47d (25.5 mg, 0.111 mmol,
4
1
(4£4 mL). The extractions were combined, and the solvent
was removed by rotary evaporation. The crude product was
purified by column chromatography (EtOAc/hexanes¼1:4)
to give an inseparable mixture of 46f and 47f (43.1 mg,
1%, 46d/47d¼71:29 measured by integration on 400 MHz
H NMR spectrum) as a colourless, transparent liquid. Rf
0.229 mmol, 85%, 46f/47f¼62:38 measured by integration
1
0
.31 (EtOAc/hexanes¼1:19); IR (neat) 3086 (w), 3060 (w),
026 (m), 2965 (s), 2878 (m), 1740 (s), 1602 (w), 1495 (m),
471 (m), 1449 (m), 1376 (s), 1360 (s), 1302 (m), 1240 (s),
on 400 MHz H NMR spectrum) as a yellow solid. R 0.37
f
3
1
1
(EtOAc/hexanes¼1:4); IR (neat) 3366 (br s), 3085 (w),
3059 (w), 3025 (w), 2954 (s), 2877 (m), 2493 (br w), 1601
(m), 1494 (m), 1472 (w), 1449 (m), 1344 (m), 1303 (m),
1266 (m), 1147 (m), 1121 (w), 1085 (m), 1054 (s), 1019
2
1
1
152 (w), 1048 (s), 1032 (s), 1015 (s) cm ; H NMR
(
CDCl , 400 MHz) d 7.15–7.31 (m, 5H), 4.79 (ddd, 0.29H,
3
2
1
1
J¼7.0, 1.2, 1.0 Hz), 4.73 (dd, 0.71H, J¼7.2, 2.7 Hz), 2.70–
(s) cm ; H NMR (CDCl , 400 MHz) d 7.23–7.32 (m,
3
2
2
.72 (m, 1H), 2.69 (s, 0.29H), 2.44–2.48 (m, 1.71H), 2.04 (s,
.13H), 2.03 (s, 0.87H), 1.95 (m, 0.71H), 1.85 (ddd, 0.29H,
4H), 7.15–7.19 (m, 1H), 4.28–4.36 (m, 1H), 3.56 (dd,
0.62H, J¼8.9, 6.0 Hz), 2.90 (dd, 0.38H, J¼11.6, 5.4 Hz),
2.47 (ddd, 0.38H, J¼12.9, 9.1, 2.3 Hz), 2.40 (s, 0.62H), 2.39
(s, 0.38H), 2.33–2.35 (m, 1H), 2.11 (ddd, 0.38H, J¼13.1,
10.1, 4.8 Hz), 2.03 (ddd, 0.62H, J¼9.6, 4.2, 1.9 Hz), 1.93
(ddd, 0.62H, J¼12.0, 9.2, 2.3 Hz), 1.76 (m, 0.62H), 1.61–
1.65 (m, 2H), 1.56 (d, 0.38H, J¼4.1 Hz), 1.31–1.37 (m,
1H), 1.08 (dt, 0.38H, J¼13.0, 3.4 Hz), 0.97 (dt, 0.62H,
1
3
J¼13.6, 6.8, 1.8 Hz), 1.50–1.76 (m, 5H); C NMR (APT,
CDCl , 100 MHz)majorisomer(46d):d 170.9, 146.3,128.28,
3
1
27.0, 125.69, 77.2, 45.9, 42.0, 41.9, 40.3, 33.1, 32.7, 21.4;
minor isomer (47d): d 170.7, 145.6, 128.33, 127.1, 125.74,
7.6, 47.8, 42.2, 39.0, 37.8, 35.8, 33.3, 21.4. HRMS calcd for
C H O : m/z 230.1307, found m/z 230.1285.
7
1
5 18 2
1
3
J¼12.9, 3.6 Hz); C NMR (APT, CDCl , 100 MHz) major
3
4
[
.4.15. 2-endo-Methoxycarbonyl-5-exo-phenylbicyclo-
2.2.1]heptane (46e) and 2-endo-methoxycarbonyl-6-
exo-phenylbicyclo[2.2.1]heptane (47e) (Table 3, entry
0). A solution of norbornene 4e (41.4 mg, 0.272 mmol) in
isomer (46f): d 147.1, 128.3, 127.3, 125.4, 72.9, 49.2, 39.5,
38.4, 37.7, 36.3, 35.5; minor isomer (47f): d 147.1, 128.3,
127.0, 125.5, 72.4, 47.1, 43.4, 43.0, 40.9, 35.3, 29.4. HRMS
calcd for C H O: m/z 188.1201, found m/z 188.1208.
1
1
3 16